200 related articles for article (PubMed ID: 23771665)
21. Hypoxia-inducible factor 1α in combination with vascular endothelial growth factor could predict the prognosis of postoperative patients with oesophageal squamous cell cancer.
Shao JB; Li Z; Zhang N; Yang F; Gao W; Sun ZG
Pol J Pathol; 2019; 70(2):84-90. PubMed ID: 31556558
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.
Liu WB; Xu GL; Jia WD; Li JS; Ma JL; Chen K; Wang ZH; Ge YS; Ren WH; Yu JH; Wang W; Wang XJ
Med Oncol; 2011 Dec; 28 Suppl 1():S228-38. PubMed ID: 20957524
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
Sun W; Shen ZY; Zhang H; Fan YZ; Zhang WZ; Zhang JT; Lu XS; Ye C
Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
[TBL] [Abstract][Full Text] [Related]
24. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
25. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
Shao N; Han Y; Song L; Song W
J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between hypoxia inducible factor-1α and esophageal squamous cell carcinoma: a meta analysis].
Jing S; Wang J; Liu Q; Cheng Y; Yang C; Wang Y; Cao F; Wen B; Jiao W; Guo Y
Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):593-9. PubMed ID: 25471499
[TBL] [Abstract][Full Text] [Related]
28. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.
Chen Y; Lu Y; Lu C; Zhang L
Pathol Oncol Res; 2009 Sep; 15(3):487-93. PubMed ID: 19130303
[TBL] [Abstract][Full Text] [Related]
29. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
30. Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients.
Xie F; Li K; Ouyang X
Clin Exp Metastasis; 2009; 26(8):1025-32. PubMed ID: 19816777
[TBL] [Abstract][Full Text] [Related]
31. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
33. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
34. Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma.
Zhang J; Zhang G; Hu P; Deng G; Liu Q; Qiao L; Luo H; Zhang J
Onco Targets Ther; 2017; 10():2923-2930. PubMed ID: 28652774
[TBL] [Abstract][Full Text] [Related]
35. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
38. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of NBS1 and Snail expression in esophageal squamous cell carcinoma.
Kuo KT; Chou TY; Hsu HS; Chen WL; Wang LS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S549-57. PubMed ID: 21881923
[TBL] [Abstract][Full Text] [Related]
40. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]